| | | 62499 | | 06.01.2012 | | AstraZeneca AG | | | | | | | | | | | | | 02.07.20. | | | | 02.07.20. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Pemzek PLUS 8/12.5 mg | Tabletten | Tablets (Candesartanum Cilexetil 8 mg, Hydrochlorothiazide 12.5 mg) | C09DA06 | CI | | 02 | Pemzek PLUS 16/12.5 mg | Tabletten | Tablets (Candesartanum Cilexetil 16 mg, Hydrochlorothiazide 12.5 mg) | C09DA06 | CI | | 03 | Pemzek PLUS 32/12.5 mg | Tabletten | Tablets (Candesartanum Cilexetil 32 mg, Hydrochlorothiazide 12.5 mg) | C09DA06 | CI | | 04 | Pemzek PLUS 32/25 mg | Tabletten | Tablets (Candesartanum Cilexetil 32 mg, Hydrochlorothiazide 25 mg) | C09DA06 | CI |
|
|
